ARCHIVES

Appropriators Ask What Happens After NIH Budget-Doubling Ends In FY2004.

This article is from The Cancer Letter archive.

Vol. 27 No. 21 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group Trials Approved Last Month By CTEP

March 26, 2010

Blood Test Could Predict Relapse, Survival For Children, Young Adults With Leukemia

May 25, 2007

Oral Complications Reduced By Pretherapy NIH Conference Finds

April 28, 1989

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012

Medicare to cut payments for cancer drugs by 2-8%. ASCO estimates total cut in reimbursement at $500 million.

July 30, 2004

NCI CTEP Approved Trials For the Month of January

January 31, 2014